HomeINMB • NASDAQ
add
INmune Bio Inc
Previous close
$7.59
Day range
$7.41 - $8.16
Year range
$4.32 - $12.72
Market cap
185.05M USD
Avg Volume
264.84K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 0.00 | -100.00% |
Operating expense | 9.47M | 12.61% |
Net income | -9.22M | -9.63% |
Net profit margin | — | — |
Earnings per share | -0.40 | 14.89% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 20.92M | -41.64% |
Total assets | 39.56M | -30.59% |
Total liabilities | 7.46M | -60.42% |
Total equity | 32.10M | — |
Shares outstanding | 22.93M | — |
Price to book | 4.24 | — |
Return on assets | -51.26% | — |
Return on capital | -63.91% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -9.22M | -9.63% |
Cash from operations | -11.01M | -223.82% |
Cash from investing | — | — |
Cash from financing | -2.08M | 16.88% |
Net change in cash | -12.63M | -111.74% |
Free cash flow | -15.97M | -5,924.20% |
About
Founded
2015
Headquarters
Website
Employees
22
